0001567619-18-003534.txt : 20181002
0001567619-18-003534.hdr.sgml : 20181002
20181002172323
ACCESSION NUMBER: 0001567619-18-003534
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180928
FILED AS OF DATE: 20181002
DATE AS OF CHANGE: 20181002
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Simon Nicholas
CENTRAL INDEX KEY: 0001431403
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38663
FILM NUMBER: 181102614
MAIL ADDRESS:
STREET 1: 101 MAIN STREET SUITE 1210
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gritstone Oncology, Inc.
CENTRAL INDEX KEY: 0001656634
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5858 HORTON STREET, SUITE 210
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 871-6100
MAIL ADDRESS:
STREET 1: 5858 HORTON STREET, SUITE 210
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
4
1
doc1.xml
FORM 4
X0306
4
2018-09-28
0
0001656634
Gritstone Oncology, Inc.
GRTS
0001431403
Simon Nicholas
101 MAIN STREET, SUITE 1210
CAMBRIDGE
MA
02142
1
0
1
0
Common Stock
2018-09-28
4
P
0
333333
15
A
333333
I
See Footnote
Common Stock
2018-10-02
4
C
0
2234112
A
2567445
I
See Footnote
Series A Convertible Preferred Stock
2018-10-02
4
C
0
1565216
0
D
Common Stock
1565216
0
I
See Footnote 1
Series B Convertible Preferred Stock
2018-10-02
4
C
0
668896
0
D
Common Stock
668896
0
I
See Footnote
Consists of the shares held by Clarus Lifesciences III, L.P. ("Clarus"). Clarus Ventures III GP, L.P. ("GPLP"), as the sole general partner of Clarus may be deemed to beneficially own certain of the shares held by Clarus. The GPLP disclaims beneficial ownership of all shares held by Clarus in which the GPLP does not have an actual pecuniary interest. Clarus Ventures III, LLC ("GPLLC"), as the sole general partner of the GPLP, may be deemed to beneficially own certain of the shares held by Clarus. The GPLLC disclaims beneficial ownership of all shares held by Clarus in which it does not have an actual pecuniary interest. The Reporting Person, as an individual managing director of GPLLC disclaims beneficial ownership of all shares held of record by Clarus in which he does not have an actual pecuniary interest.
The Series A Convertible Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
The Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
/s/ Dana B. Johnson, Attorney-in-Fact for Nicholas Simon
2018-10-02